Omeprazol Basi (Omeprazole)

Omeprazole, the active ingredient in Omeprazol Basi, is a proton pump inhibitor presented as a unknown strength/unknown form for oral use. It reduces stomach acid production and is used to manage gastro‑reflux and other acid‑related disorders in adults and children. GNH USA supplies Omeprazol Basi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Omeprazol Basi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazol Basi is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related conditions: - Gastro‑oesophageal reflux disease (GERD): alleviates heartburn and promotes healing of the oesophageal lining. - Peptic ulcer disease: supports ulcer healing by reducing gastric acidity. - Zollinger‑Ellison syndrome: controls excessive gastric acid production associated with this rare endocrine disorder. - Helicobacter pylori eradication regimens: used as part of combination therapy to improve eradication rates. - NSAID‑induced gastropathy: helps prevent ulcer formation in patients requiring long‑term non‑steroidal anti‑inflammatory drugs.

Omeprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: typically self‑limiting. - Nausea: occasional and transient. - Abdominal pain or discomfort. - Flatulence: mild bloating. - Constipation: occasional.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): rash, swelling, difficulty breathing. - Clostridioides difficile infection: persistent watery diarrhea. - Low magnesium levels (hypomagnesemia): muscle cramps, irregular heartbeat. - Bone fractures: increased risk with long‑term use. - Acute interstitial nephritis: kidney inflammation. - Liver enzyme abnormalities: elevated ALT/AST.

When prescribing Omeprazol Basi, clinicians should consider several safety aspects.

- Assess renal and hepatic function: adjust use if impairment is present. - Review long‑term therapy need: limit duration to the shortest effective period. - Monitor for vitamin B12 deficiency: prolonged acid suppression may affect absorption. - Caution in pregnancy and lactation: weigh benefits against potential risks. - Avoid concomitant use with drugs that require acidic environment for absorption unless medically necessary. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Omeprazole can affect the pharmacokinetics of several co‑administered medicines.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, may increase cardiovascular risk. - Atorvastatin: increased plasma concentrations, heightened risk of myopathy. - Methotrexate: elevated levels, potential toxicity.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR, monitor coagulation parameters. - Digoxin: altered absorption, check serum levels. - Phenytoin: reduced serum concentration, monitor seizure control.